Computerized cognitive rehabilitation for Multiple Sclerosis

Phase-Based Progress Estimates
Multiple Sclerosis+1 MoreComputerized cognitive rehabilitation - Other
18 - 65
All Sexes
What conditions do you have?

Study Summary

This trial looks at whether a home-based computer program can help improve thinking skills in adults with multiple sclerosis, compared to a placebo group who play a videogame. Patients are assessed before and after the intervention.

Eligible Conditions
  • Multiple Sclerosis
  • Cognitive Impairment

Treatment Effectiveness

Study Objectives

1 Primary · 5 Secondary · Reporting Duration: 12 Months

12 Months
Healthcare Utilization
6 Months
Cognitive Functioning
Multiple Sclerosis Self-Efficacy Scale
6 months
Hospital Anxiety and Depression Scale
Multiple Sclerosis Quality of Life Inventory
Six-minute Walk Test
Timed Up & Go Test
Work Productivity and Activity Impairment Instrument

Trial Safety

Trial Design

2 Treatment Groups

1 of 2
1 of 2

Experimental Treatment

Non-Treatment Group

80 Total Participants · 2 Treatment Groups

Primary Treatment: Computerized cognitive rehabilitation · Has Placebo Group · N/A

Experimental Group · 1 Intervention: Computerized cognitive rehabilitation · Intervention Types: Other
ShamComparator Group · 1 Intervention: Sham placebo · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 12 months

Who is running the clinical trial?

Rutgers, The State University of New JerseyLead Sponsor
376 Previous Clinical Trials
58,548 Total Patients Enrolled
4 Trials studying Multiple Sclerosis
96 Patients Enrolled for Multiple Sclerosis
Horizon Blue Cross Blue Shield of New JerseyOTHER
3 Previous Clinical Trials
7,249 Total Patients Enrolled

Eligibility Criteria

Age 18 - 65 · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Who else is applying?

What state do they live in?
North Carolina100.0%
How old are they?
18 - 65100.0%
What portion of applicants met pre-screening criteria?
Met criteria100.0%